ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000214.1|Cosmomycin_1 # 3 # 407 # -1 # ID=1_1;partial=10;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.768	BGC0000214.1|Cosmomycin_1 	3	407	-	Loose	200	27.335	vanH gene in vanO cluster	45.65	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	GTGGCAGTCCTCCGGCATCGGCGCCTCGAGCTGAGCACGGCGATGTCCACCACCACGCAGGGCGGGGCGGCCGTCGGCACCGTGGCCGTGCTCGGCGCCACGGGGTGCGTCGGCCGCAGCGTCTGTGACGAACTGTCGCGCACCGGGCACCGGGTGCTGGCGGTGGCCCGGCACCCGGCGCCCCACACCCGCCCGCACGCCTTCGTCCCCCTCGACGTCGCCGGGACCGCGCCGGAGCGTCTCGCCGCGCTCCTCGACCGGTACGGCGTCACCGCGGTGGTCAATGCCACCGGCGGCTGGGGCACCACCGTCGAGGAGATGCGCCGGGCCCACATCGACCTCCTGGAGCGCCTGGTCGACGGCTGTGCCGCGACCTCCCGGCGGCTGCGGGTCGTCCAGCTGGGG	MAVLRHRRLELSTAMSTTTQGGAAVGTVAVLGATGCVGRSVCDELSRTGHRVLAVARHPAPHTRPHAFVPLDVAGTAPERLAALLDRYGVTAVVNATGGWGTTVEEMRRAHIDLLERLVDGCAATSRRLRVVQLG	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	38.57	gnl|BL_ORD_ID|761|hsp_num:0	786			528	654	vancomycin
BGC0000214.1|Cosmomycin_3 # 1074 # 2366 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.705	BGC0000214.1|Cosmomycin_3 	1074	2366	-	Loose	700	48.9062	oleI	30.37	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGGGTACTCTTCACCACCTTCGCCGCCAAGTCGCACATGCACGCCCAGGTCACACTCGCCTGGGCCCTCAAGGCGGCGGGCCACGACGTCAGGATCGCCAGTCACCCCGATCTCGCCGACGAGATCACCCGTACCGGGCTGACCGCCGTCGGGGTCGGGGAGGAACTGCATCTCGACGAGCAGATGCAGGAGACCCAGGAGAACATCGGCCAGGACGTCGACCAGCTGGAGAGCCAGGCACAGGTCGGTCTCGACATGAGCGAGACCCGCCCGGAGCGGCTCACCTGGGACTACACACTCGGTGTGTTCACGGCCATGACCTCGGTCGTCTTCCAGAACTGCTGCTCCGACCAGATGGTCGACGAGCTGGTGGAGCACTGCCGCTCCTGGAAGCCCGACCTGGTCCTGTGGGACACCATGACCTTCGCGGGCGCCATCGCCGCCATGGCCACGGGGACGGCGCACGGCCGGCTGCTCTTCGGGATGGACCTGGCGGGCAAGATGCGCGAGACCTTCCTGGAGCAGCTGGCGGCGCGTCCGCCGGAGCTGCGGGACGACCCGCTGCGCGAGTGGCTCACCTGGAGCCTGGAGCGGCACGGCGCCTCCTTCGAGGAGGCCGCGGTGACGGGCGACTTCACCGTCTGCCCGCTGCCGGCGTCCATGCGGTTCCCGCTGGACCTGCACTACGTGCCGATGCGGTACGTGCCGTACAACGGCCAGTCCACCGTGCCGCAGTGGCTCCAGGAACCGCCGAAGCGGGGCCGCCGGGTGTGCATCACGCTGGGTGTGGCGCACCGCGAGGTGCTGGGCGCCGACCGGGCGTCCATCGGCGACCTGCTGGAGGCCGTCGCGGGGCTCGACGACGTCGAGGTCGTCGCCACGCTCAACGAGAACCAGCTGAAGGACTTCGACACCCTGCCGGACAACGTGCGGGCCGTCGACTTCGTCCCGCTCGACGCGCTGCTGCCCACCTGCGACGCGGTGATCCACCACGGCGGGTCGGGCAGCTTCGGCACGGCGATGATCCACGCCGTGCCCCAGCTCATCGTCGTCGACGGCGTCTGGGACACCATCAACAAGGCCCGCTACCTGGAACGGCGCCAGGCCGGGCTCTACGTGCCCGGCAAGCTCAGCGCGAAGGGACTGCGCGAGCTGCTCGTCCGCCTGCTCGAGGAACCGGTCTTCAAGCGCAACGCCGAGGCCCTGCGGCGCGAGGCGCTCGCCGCTCCCGCCCCCGCGCAGGTCGTCCCCACGCTGGAGCGCCTGGCCGCCGAGCACCGCCGCCGGTGA	MRVLFTTFAAKSHMHAQVTLAWALKAAGHDVRIASHPDLADEITRTGLTAVGVGEELHLDEQMQETQENIGQDVDQLESQAQVGLDMSETRPERLTWDYTLGVFTAMTSVVFQNCCSDQMVDELVEHCRSWKPDLVLWDTMTFAGAIAAMATGTAHGRLLFGMDLAGKMRETFLEQLAARPPELRDDPLREWLTWSLERHGASFEEAAVTGDFTVCPLPASMRFPLDLHYVPMRYVPYNGQSTVPQWLQEPPKRGRRVCITLGVAHREVLGADRASIGDLLEAVAGLDDVEVVATLNENQLKDFDTLPDNVRAVDFVPLDALLPTCDAVIHHGGSGSFGTAMIHAVPQLIVVDGVWDTINKARYLERRQAGLYVPGKLSAKGLRELLVRLLEEPVFKRNAEALRREALAAPAPAQVVPTLERLAAEHRRR	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	101.42	gnl|BL_ORD_ID|1684|hsp_num:0	1824			714	1266	oleandomycin
BGC0000214.1|Cosmomycin_4 # 2613 # 3176 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.715	BGC0000214.1|Cosmomycin_4 	2613	3176	+	Loose	535	27.335	aadA10	35.14	3004692	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGTCCGCCACGCGATTGCTCGTCCTGGGGGTCGTGCGGATGCACGGCCGGGCGCACGGCTATCTGGTCCGCTCCGAGCTGTTGTCCTGGGGTGCCGACGAATGGGCGCACATCAAGTTCGGCTCGATCTACCACGCGCTCAGGCAGCTGGCCAAGGACGGCCTGCTGAAGTCGACCGACATCCCCGACTGGCCCGGCCGCGTCGACTACGAGATCGCGCCCCCGGGCGAGGAGGAGTTCTTCCGGCTGCTGCGCGACGCGCTGCGCCAGGGGAACAACCGACCGGACATGCTGGGGGCGGCGCTCGTCCTGCTGCCGGCGCTCAGCCGCGAGGAGGCGATCGCCCTGTTGCGGGAGCGCATCGCGTCGCTCTCGGCGGAGCAGGGTGAGCTGATCGCGAAGGTCGACGAGACGGCGGGCGAGCGGCCGCAGCGGGCCCACATCCGCGAACTCCTCGGCCTCTGGGAGCACAGCGCCGCGAGCCAGGCCGCCTGGACCGAGGCACTGATCGAGCGCCTGGAGGCGGGCGCCTACGTCATGGCGGGGGAGGAGAAGGGCGCCTGA	MSATRLLVLGVVRMHGRAHGYLVRSELLSWGADEWAHIKFGSIYHALRQLAKDGLLKSTDIPDWPGRVDYEIAPPGEEEFFRLLRDALRQGNNRPDMLGAALVLLPALSREEAIALLRERIASLSAEQGELIAKVDETAGERPQRAHIRELLGLWEHSAASQAAWTEALIERLEAGAYVMAGEEKGA	MRNTVPAEISVQLSQALNVIEHHLGSTLLAMHLYGSALDGGLKPYSDIDLLVTVTARLDESVRQALFVDLLGVSVFPGQSRVLRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAGIFEPATTDVDLAILLTKARQHSLALAGSAAEDFFNPVPESDLFKALADTLKLWNSQPDWIGDERNVVLTLSRIWYSAATGKIAPKDVAANWVMERLPVQHQPVLLEARQAYLGQGEDCLASLTDQLEAFVHFVKHEATKLLGATPMMSKTKLDALST	67.51	gnl|BL_ORD_ID|2153|hsp_num:0	3398			465	576	spectinomycin; streptomycin
BGC0000214.1|Cosmomycin_6 # 4378 # 4713 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.714	BGC0000214.1|Cosmomycin_6 	4378	4713	+	Loose	2000	24.2534	adeJ	42.11	3000781	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCAGCCGATCAGCCCGGCCCCGCCTCCGGCGGCCCGGCCACCTTCGTCAACAGCTTCACCCTCCGCACCACCCCGGAGGAGTTCGAGGACGTCTTCGCCCGCACGGCACGCTTCATGGAGCGCCAGCCCGGCTTCCTCGGCTACACCCTCGTACGCCACCTGGAACAGCCGCACAGCTACGTCAACATCGCCCGCTGGGCCGACGTCGCCTCCTTCCGCGCCGCGGTCGGCCAGAGCGACTTCCGGCCGCACGCCGAGGCGCTGCGGGCGATCAGCACCAGCAGCTCCAACCTCTACCTGGAGCGGCGCAGCGCCACCGGGGAGGCGCGATGA	MSADQPGPASGGPATFVNSFTLRTTPEEFEDVFARTARFMERQPGFLGYTLVRHLEQPHSYVNIARWADVASFRAAVGQSDFRPHAEALRAISTSSSNLYLERRSATGEAR	MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENTVTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPEDVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANALDTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQNWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGKIFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFFMNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIKDASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPNGQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGDAMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESWSIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEFAKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLGGVLSATFLGIFFIPVFYVWIRSMFKYKPKTINTQEHKS	10.49	gnl|BL_ORD_ID|574|hsp_num:0	630			699	756	tetracycline; rifampin; imipenem; trimethoprim; chloramphenicol; ticarcillin
BGC0000214.1|Cosmomycin_8 # 5975 # 7219 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.761	BGC0000214.1|Cosmomycin_8 	5975	7219	+	Loose	600	33.113	MSI-1	34.38	3003718	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MSI beta-lactamase	ATGACCCCCGTCGTGGTCACGGGCATCGGCGTCGTCGCCCCCACCGGCATCGGACTCGACGCCTACTGGGCGGCGACCCTGCGCGGCGACGACGGCATCCGGCGCGTGCAGGCGTTCGACCCCAGCCGCTATCCGACCCGCCGGGCCGGGGAGGTGACCGGGTTCGAGGCGGGCGACCACCTGCCGAGCCGGCTGATCCCGCAGACCGACCGCATGACCCAGTTCGCCCTGGCCGCGGCCGACTGGGCCGTCGCCGACGCCGGCATCGACCTCGACGCGGTGCCGTCGCTGGAACGCGGCGTCGTCACGGCCGGTGCCTCCGGCGGCTTCGGCTTCGGCCAGCGCGAACTCCAGCACCTGTGGGGCGAGTCCCCCAAGAAGGTCAGCGCCTACATGTCCTTCGCCTGGTTCTACGCCGTCAACACCGGCCAGATCTCCATCCGGCACGGCATGAACGGGCCGACCGGCGTCTTCGTCGGCGAGCAGGCCGGCGGCCTGGACGCCCTCGCCCACGCCCGGCGCCAGATCCGCGCGGGGGCCCGGCTGATGATCTCCGGCGGCATGGACTGCTCCCTGTGCCCGTACGGCATGGCCGCCCAGCTGGCCGGCGGACGGCTCACCGCCGACGCCTACCTGCCCTTCGACGACCAGGCCTCCGGTCATCTGCCCGGCGAGGGCGGGGCGTTGCTCACCCTGGAGAGCGCCGAGGGGGCCCGGGCGCGCGGACGCGGTCACTACGGCGAGATCGCCGGGTTCGGCGCCACCTTCGACCCGCGCCCCGGGTCCGGGCGCCCCCCGGCCCTGCGCCGGGCCGTCGAGCAGGCGCTCGCCGACGCCCAAGCCGCGCCGGAGGACATCGCCGTCGTCTTCGCCGACGGTGCCGGCGTGCCCGAACTCGACGCGGCCGAGGCCGCGGCGCTCACCGAGGTCTTCGGCCCGGGAGGAGTCCCGGTCACGGTGCCCAAGACGGCCACCGGCCGGCTCTACTCCGGTGCCGGGCCGCTCGACGTGGTCACCGCCCTGCTGACCCTGCGCGACGGGATCGCCCCGCCCACGGTCAACGTCTCGCGGGTGCCCGACACGTACGGCCTCGACCTCGTCCTCGGACGGCCCCGGCCGGTCTCCGGCACGGCGGCCCTGGTCCTGGCCCGCGGCCACCACGGCTTCAACAGCGCCCTGGTCGTCCGGGCCCCCGCGCCCGGCGACGCCGTCGCGCACCGGCCCGAGGAGAGGACGGCGGCGTGA	MTPVVVTGIGVVAPTGIGLDAYWAATLRGDDGIRRVQAFDPSRYPTRRAGEVTGFEAGDHLPSRLIPQTDRMTQFALAAADWAVADAGIDLDAVPSLERGVVTAGASGGFGFGQRELQHLWGESPKKVSAYMSFAWFYAVNTGQISIRHGMNGPTGVFVGEQAGGLDALAHARRQIRAGARLMISGGMDCSLCPYGMAAQLAGGRLTADAYLPFDDQASGHLPGEGGALLTLESAEGARARGRGHYGEIAGFGATFDPRPGSGRPPALRRAVEQALADAQAAPEDIAVVFADGAGVPELDAAEAAALTEVFGPGGVPVTVPKTATGRLYSGAGPLDVVTALLTLRDGIAPPTVNVSRVPDTYGLDLVLGRPRPVSGTAALVLARGHHGFNSALVVRAPAPGDAVAHRPEERTAA	MGARSCSRAWCCSRATRSAPPGRRSGRLSCARCRRPSTGCNPSSTPPITGDIMKHIRLACVAAGLVAAASSVSAIGADWNAPQEPFALFGNSYYVGPHGVASVLITSNQGHILIDGGSDKSPPQIAARIRQLGFKPEDIRFILVSHEHIDHAGGVAELQRLSNAEVLAGAAAVPVLHSGEAGRNDPQYGGLPKMAPVARVRAVRDGEVVKLGPLAVTMHATPGHTQGGASWTWQSNEGGRTANMVYADSLTAFGSGGFRYSGDARYPSARADVERSIAKVAALPCDILVSAHPEVSELWTRYERRAAQGNAAFIDAGACKAYAVKARVKLQEQLARETAKP	121.41	gnl|BL_ORD_ID|2030|hsp_num:0	2233			675	867	
BGC0000214.1|Cosmomycin_10 # 8247 # 9296 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.783	BGC0000214.1|Cosmomycin_10 	8247	9296	+	Loose	400	26.5646	Erm(30)	50.0	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAACGACGTCCGCACGGCAGCGGACGGGCGGGACGGCGGTACGCGCCCGGTCGCCCTGCTGCTGCCCGGCCAGGGAGCACAGCACCCGCGCATGGCGGCGGGCCTCCTGGCCGCCGAGCCCGTCTTCGCGGAGGCGATGGACGAGGCCCTGACCGCCCTGGCGGACGCCGGTGGGCCGGGCGGCCACGGCACCGGCCTGCGCGAGGACTGGCTCGGGTCCCGCGACACCGCGCTGATGGACCACGTCACGCGCTCCCAGCCCCTGCTCTTCGCGGTGGACTACGCCATCGGGCGGCTCGTGCTCGGCTGGGGCGTGCGGCCCGTCGCCCTGCTCGGCCACAGCATCGGCGAGGTGGCGGCCGCGGTCCTCTCCGGCGTCTTCACGCTGCCGGACGCCGCCGCCATGGTGCACGACCGCGTCGCCCGGCTGGCGGACGCGCCGCCCGGCGGGATGGTCGCCGTCGCCGCCACCCGGGAGGAGGTGGCGCCCTTCCTCACCGACGGCGTGGTCGTCGGCGCCGTCAACGCCCCGCGGCAGACGGTCCTGGCCGGACTCGACGGCCCGCTGCGCACCGTCACGGCGGCACTGGCCGACGCCGGGTTCGTGCTCCAGCGCGTACCCGCCTCCACGGCGTTCCACAGCCCCGCCCTCGCCCCGGCGATGCGCGGTGCCGACGAGCGGATCGCCGCCCTGCCCGTCGGCGAGCCCCGGATCCCGGTCATGTCCGGGTACACGGGCCGGTTCCTGACGCCCGCGGAGGCGAAGGACCCGGCCTTCTGGAGCAGGCAGCCGGTGGCGCCGGTGCTGTTCTGGCCCGCCCTCGACGCCCTCCTCGCCCAGGGCGACCCGGTGCTCGTGGAGGCCGGTCCGGGGCAGGGGCTGTCGCAGCTGGCCCGCCGCCACCCGGCCGTGCGCTCCGGCCGCTCCGCCGTCGTCCCGCTGCTGCCGGCCCGGCCGGGAACCGCCGAGGACGACGTGACCGCCGTACGCGCCGCCGCCGCGGCGCTACGGGAACGCGCCGGCGTACCGGACGCGCGGCCCGTGTAG	MNDVRTAADGRDGGTRPVALLLPGQGAQHPRMAAGLLAAEPVFAEAMDEALTALADAGGPGGHGTGLREDWLGSRDTALMDHVTRSQPLLFAVDYAIGRLVLGWGVRPVALLGHSIGEVAAAVLSGVFTLPDAAAMVHDRVARLADAPPGGMVAVAATREEVAPFLTDGVVVGAVNAPRQTVLAGLDGPLRTVTAALADAGFVLQRVPASTAFHSPALAPAMRGADERIAALPVGEPRIPVMSGYTGRFLTPAEAKDPAFWSRQPVAPVLFWPALDALLAQGDPVLVEAGPGQGLSQLARRHPAVRSGRSAVVPLLPARPGTAEDDVTAVRAAAAALRERAGVPDARPV	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	103.87	gnl|BL_ORD_ID|1123|hsp_num:0	1224			627	699	narbomycin; methymycin; pikromycin
BGC0000214.1|Cosmomycin_12 # 10725 # 12005 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.724	BGC0000214.1|Cosmomycin_12 	10725	12005	+	Loose	700	55.8398	oleI	34.02	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	GTGCGTGTACTGCTGACAGCCTTCGCACAGGACGCCCATCTCAACGGCATCGTTCCGCTCGCCTGGGCGCTGCGGACCGCCGGGCACGAGGTCCGGGTGGCCGGCCAGCCGGCCGCGGTCGAGAGCATCACCCGGGCCGGTCTGACGGCCGTGCCGGTGGGCGACGACCACCGGATGGACGCCGTCATCCCCACCGTCGGTCCCGGGATGCTCATGCACCACCTGGACCGCGACTACCTGGAGAACCGCCCGGAGCGGCTGAGCCTCGACTTCCTGCGGGCGTCGAACGCGATGCTGACGGCGACCTTCTACGCGCAGATCAACAACGACTCGATGATCGACGCGCTCGTCGACTACGCCCGGTTCTGGCAGCCGGACCTGGTGCTCTGGGAGCCCTTCACCTTCGCCGGCGCCGTCGCCGCCAAGGCGACCGGGGCCGCCCACGCCCGGCTCCTGGCCTTCCCCGACCTGTTCGCGAACACCCACCTGACGCTGCGCCGGCGGCAGGCGGAACTGCCCGCGGAACTGCGCGACGACCCGCTGGAGGAGTGGCTGGCGTACACCCTCGACCGGCACGGCGCCGCCTTCGACCCCGACGTGGTCACGGGGCAGTGGTCGGTCGACCAGATGCCCCCCGGCGTGCGGATGGAGCTGGGGCTGCCGACGGTGCCCACGCGTTACGTGCCGTACAACGGTCCGGGTCCGGCCGTCGTGCCGGACTGGCTGCGCCGGCCGCCGGAGCGCCGCCGGGTCTGCCTCACCCTCGGGCTCACCATCCGGGACACGGAGTTCCCCAACGCCGTCGACGTCGACGACGTCTTCGCCTCGCTGGCCGACCTGGACGTCGAGGTGGTGGCGACGCTGAGCGAGAAGGAACTCGCCCAGGTGTCGCGGGTGCCGGACAACACGCGGGTGGTCGACCACGTGGCCCTGCTGGCCCTGCTGCCCAGTTGCTCGGCGATCGTCCACCACGGCGGTGCCGGGACGTGGGCGACCGCCGCCGCGTACGGGGTGCCGCAGGTGGCGCTCGGCTGGATGTGGGACGCGATCTACCGCGCGCAGCGGGTGGAGGAGCTGGGGGCGGGGCTGCACCTGCACTCCGAGGGCCTGACCGTCGAGGTCCTGCGCGACAAGCTCGTGCGGGTGCTCGACGACCCCTCGTTCACGGAAGGCGCCCGACGGCTGCGTCTGGCCATGCTGTCGGCGCCGAGCCCCAACGAAGTGGTGCCCACACTCGAGAAACTGACGGCGCGTCACCGCTCGGTGGCCGCGGCCCGCTGA	MRVLLTAFAQDAHLNGIVPLAWALRTAGHEVRVAGQPAAVESITRAGLTAVPVGDDHRMDAVIPTVGPGMLMHHLDRDYLENRPERLSLDFLRASNAMLTATFYAQINNDSMIDALVDYARFWQPDLVLWEPFTFAGAVAAKATGAAHARLLAFPDLFANTHLTLRRRQAELPAELRDDPLEEWLAYTLDRHGAAFDPDVVTGQWSVDQMPPGVRMELGLPTVPTRYVPYNGPGPAVVPDWLRRPPERRRVCLTLGLTIRDTEFPNAVDVDDVFASLADLDVEVVATLSEKELAQVSRVPDNTRVVDHVALLALLPSCSAIVHHGGAGTWATAAAYGVPQVALGWMWDAIYRAQRVEELGAGLHLHSEGLTVEVLRDKLVRVLDDPSFTEGARRLRLAMLSAPSPNEVVPTLEKLTARHRSVAAAR	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	100.47	gnl|BL_ORD_ID|1684|hsp_num:0	1824			891	1182	oleandomycin
BGC0000214.1|Cosmomycin_13 # 12028 # 13011 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.712	BGC0000214.1|Cosmomycin_13 	12028	13011	+	Loose	1200	40.817	arnA	23.64	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGAACATCCTGGTGACCGGTGCGGCCGGCTTCATCGGCTCGCACTTCGTCAGAACGCTGCTGAGCGGCGGGTACCCCGGGCACGAGGACGACCGGGTGACCGTCCTGGACAAGCTCACCTACGCGGGGACGCTGAACAACCTGCCGGCGCACCACCCGCGGCTGACCTTCGTGCACGGCGACATCTGCGACACCACCCTGCTGGACAAGGTGTTCCCGGGCCACGAGGCGGTCGTCCACTTCGCCGCGGAGTCGCACGTCGACCGCTCGGTGGCGGGCGCCGAGGCCTTCGTCCGCACCAACGTGCTCGGCACGCAGGCCCTGCTCGAAGCGGCGCTGCGGCACGGGATCGGCGTCTTCGTCCAGGTCTCCACGGACGAGACGTACGGTTCCATCGCCGAGGGGCGCTGGACGGAGGACGAGCCGCTGCTGCCCAACTCGCCCTACGCGGCGTCCAAGGCGTCGGCCGACCTCATCGCCCGGTCGTACTGGCGCACCCACGGCCTCGACGTGCGCATCACCCGCTGCGCCAACAACTACGGCCCCGGCCAGCACCCCGAGAAGCTGGTCCCGCTGTTCGTCACCCGGCTCCTCGACGGGCAGCCGGTCCCGCTGTACGGGGACGGCTCGAACCTGCGCGAGTGGCTGCACGTGGACGACCACTGCCACGCGGTGCGGCTGGTGCTGGACCGGGGCCGGCCGGGGGAGGTCTACAACGTCGGCGGCGGCACCCACCTGACCAACAAGGAGATGACCGGCCGCCTCCTCGCACTCTGCGGACGCGACTGGGACCTCGTGCGGCGGGTGGCGGACCGCAAGGGGCACGACTTCCGGTACGCCGTGGACGACTCCAAGATCCGCCGCGAACTGGGCTACGCGCCCCGCTGGTCGCTCGAGGACGGGCTGCGCGAGACGGTCGAGTGGTACGCCGCCCACCGTGACCACTGGGACGCCCGGGAGGAAGGCGCCGACGAGGGGTACTAA	MNILVTGAAGFIGSHFVRTLLSGGYPGHEDDRVTVLDKLTYAGTLNNLPAHHPRLTFVHGDICDTTLLDKVFPGHEAVVHFAAESHVDRSVAGAEAFVRTNVLGTQALLEAALRHGIGVFVQVSTDETYGSIAEGRWTEDEPLLPNSPYAASKASADLIARSYWRTHGLDVRITRCANNYGPGQHPEKLVPLFVTRLLDGQPVPLYGDGSNLREWLHVDDHCHAVRLVLDRGRPGEVYNVGGGTHLTNKEMTGRLLALCGRDWDLVRRVADRKGHDFRYAVDDSKIRRELGYAPRWSLEDGLRETVEWYAAHRDHWDAREEGADEGY	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	49.40	gnl|BL_ORD_ID|1513|hsp_num:0	1643			957	1701	polymyxin B
BGC0000214.1|Cosmomycin_14 # 13087 # 14076 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.700	BGC0000214.1|Cosmomycin_14 	13087	14076	+	Loose	650	321.627	tetA(58)	50.78	3003980	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGGCGGCGCCGACCTGGCGATCCAGACCGAAGCTCTGAAGAAGAAATACGGCGACAAGGAGGCCCTCGCGGGACTCGACCTGGAGGTACCCCGAGGCGTCGTCTACGGGCTCCTCGGCCCGAACGGCGCCGGAAAGACCACCGCGGTCCGCATCCTCTCCACCCTGCTGAAGTACGACGAGGGAACAGCCCGGGTCGCCGGCTACGACGTCGCCACCCAGTCGGCCCAGGTCCGCTACAGCATCGGACTCCTCGGCCAGCACGCCGCAGTGGACGAGGACCTGAGCGGCCGTCAGAACCTCGTGATGTTCGGGCGCTTATACCACATCGGTAAACGCAACGCCCAGGCCCGGGCCGACGAACTGCTGGAGCGCTTCGGCCTCACCGAGGCCGCCGGCAAGCCGGCCAAGCAGTACTCCGGCGGTATGCGCCGGCGGCTCGACCTCGCCGCCAGCCTCATCCTGGCCCCGTCCGTGCTGTTCCTCGACGAGCCCACCACCGGGCTCGACCCGCGGGGCCGCAACGACGTCTGGGAGTCCGTCCGAGGCCTGATCGCCGAGGGCCGCACGGTCCTGCTGACCACCCAGTACCTGGAGGAGGCCGACCAGCTCGCCGACCGCATCGCCCTGATCGACAACGGCAGGGTCGTCGAGTCCGGCACCCCGGACCAGCTCAAGAACAAGATCGGCGGGGACCGGATCGACGTCGTCCTCCGCCGCGCCCACGACCTCGAACGCGCCACCCACACGATCGGCACCCTGCTGCGCTCCGAGCCCGAGACGGACGCCGACAACCGGCGCATCAGCGTCGTCGTCGACAACCGGGTCGCCGCCCTCACCGCCGTCGCCCGCGAACTCGACGACGCCGGCATCGAGGCCGAGGACATCGCCCTGCGCAGGCCCACTCTCGACGAGGTGTTCCTGAACCTGACCGGCAACGGGGCGGCCACGTCCGCCGAGCAGAGCCTCAAGGAGGTCGCCCAGTCATGA	MGGADLAIQTEALKKKYGDKEALAGLDLEVPRGVVYGLLGPNGAGKTTAVRILSTLLKYDEGTARVAGYDVATQSAQVRYSIGLLGQHAAVDEDLSGRQNLVMFGRLYHIGKRNAQARADELLERFGLTEAAGKPAKQYSGGMRRRLDLAASLILAPSVLFLDEPTTGLDPRGRNDVWESVRGLIAEGRTVLLTTQYLEEADQLADRIALIDNGRVVESGTPDQLKNKIGGDRIDVVLRRAHDLERATHTIGTLLRSEPETDADNRRISVVVDNRVAALTAVARELDDAGIEAEDIALRRPTLDEVFLNLTGNGAATSAEQSLKEVAQS	MEHAYKKKIEPKPGDLAVEAYGLIKTFGDNRAVDGVDLNVRTGTIYGVLGPNGAGKTTTIRMLATLLRPDAGSARIFGHDVQAESQIVRQLIGVTGQYASVDESLSATENLIIFSRLLGLGRKEARRKAEELLEEFGLSEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRSQMWDTIRRLVNTGSTVLLTTQYLEEADQLADRIAVIDYGRVVAEGTADELKMSVGTSSLHLTVEDSVDMDRACHTVEQVLGVHANVSPEAGKITAPMANAGLVTDLLIELRTAGIGLSEMSVQKPTLDEVFLTITGHGVKEDAAQESYESNDREVARV	95.92	gnl|BL_ORD_ID|2243|hsp_num:0	2517			42	1002	tetracycline
BGC0000214.1|Cosmomycin_7 # 4710 # 5978 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.745	BGC0000214.1|Cosmomycin_7 	4710	5978	+	Loose	750	182.185	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	36.39	3003463	protein variant model	R121K, F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGACCCGGCGGGTCGTGATCACCGGCATCGGGGTGGTGGCCCCCGGCGGCATCGGCACCAAGCAGTTCTGGGAGACCGTCACCGGCGGCCGCACCGCGACCCGGACCATCAGCCTGTTCGACCCCGCCCCGTTCCGCTCCCGGATCGCGGCCGAGTGCGACTTCGACGCCGCGGAGCAGGGCCTGAGCCCCGAGGACGCCGAACGGCTCGACCGGGCGGCGCAGTTCGCCCTGGTCGCGCTGCGCGAGGCCGTCACCGACAGCGGCTTGGAGCCCGACCCCGACACCGCCCACCGCACCGGCGTCAGCCTCGGCAGCGCGGTCGGCTGCACCCAGAAACTCGAAGAGGAGTACGTCGCCCTGAGCGGCGGCGGACAGGAGTGGCTCGTCGACCACACCGCCGCCGGCGCGCACCTCTACGACCACTTCGTGCCCAGCTCCATGGCCGCCGAACTCGCCTGGGAGGCCGGCGCCGAAGGCCCCTGCACCGTCGTCTCCGCCGGCTGCACCTCCGGCCTCGACTCGGTCGGGCACGCGGCCGCCCTCATCCGCGAGGGCACCGCCGACGTGATGATCGCCGGGGCCACCGACGCCCCCATCTCCCCGATCACCGTGGCCTGCTTCGACGCCATCCGCGCCACCTCGCCCCGCAACGACGACCCGGCGACCGCGCTGCGCCCCTTCGACCGCACCCGCAACGGCTTCGTCCTCGGCGAGGGCGCCGCCGTCCTGGTCCTGGAGGAGCTGACGGCGGCCCGGCGCCGGGGCGCCCACGTGTACGCCGAGATCGCCGGCTACGCCTCCCGGGGCAACGCGTACCACATGACCGGGCTGCGCACCGACGGACGCGAGCTCGCCGCCGCCGTCGACGCCGCCCTCGACGAGGCCCGGCTCGCCCCCGAGGCACTCGGGTACGTCAACGCCCACGGCACCGCCACCAAGCAGAACGACGTGCACGAGACGGCGGCCCTCAAGCGCAGCCTCGGATCCCACGCCCACCGCGTCCCGGTCAGCTCCATCAAGTCGATGATCGGGCACTCGCTCGGCGCCATCGGCTCCATCGAGGTCGCCGCCACCGCCCTGGCCCTCGAACACGGCGTCATCCCGCCCACCGCCAACCTGACCGACCCCGACCCCGACCTCGACCTGGACTACGTCCCCCTGCACGCCAGGGAGCGGACCATGTCGGCCGCGCTCACCGTGGGCAGCGGCTTCGGCGGCTTCCAGAGCGCGGTGGTGCTGCGCCGGCCCGAGGGGCGGGCCGCATGA	MTRRVVITGIGVVAPGGIGTKQFWETVTGGRTATRTISLFDPAPFRSRIAAECDFDAAEQGLSPEDAERLDRAAQFALVALREAVTDSGLEPDPDTAHRTGVSLGSAVGCTQKLEEEYVALSGGGQEWLVDHTAAGAHLYDHFVPSSMAAELAWEAGAEGPCTVVSAGCTSGLDSVGHAAALIREGTADVMIAGATDAPISPITVACFDAIRATSPRNDDPATALRPFDRTRNGFVLGEGAAVLVLEELTAARRRGAHVYAEIAGYASRGNAYHMTGLRTDGRELAAAVDAALDEARLAPEALGYVNAHGTATKQNDVHETAALKRSLGSHAHRVPVSSIKSMIGHSLGAIGSIEVAATALALEHGVIPPTANLTDPDPDLDLDYVPLHARERTMSAALTVGSGFGGFQSAVVLRRPEGRAA	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.44	gnl|BL_ORD_ID|1968|hsp_num:0	1943			303	1245	isoniazid
